Comparison of the Effect of Exenatide vs. Sitagliptin on 24-Hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione
Phase of Trial: Phase IV
Latest Information Update: 21 Jul 2014
At a glance
- Drugs Exenatide; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Amylin Pharmaceuticals
- 20 Sep 2010 Results were presented at the 46th Annual Meeting of the European Association for the Study of Diabetes.
- 12 Feb 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 25 Aug 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History